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a b s t r a c t
Transient receptor potential, melastatin-like 7 (Trpm7) is a combined ion channel and kinase implicated
in the differentiation or function of many cell types. Early lethality in mice and frogs depleted of the
corresponding gene impedes investigation of the functions of this protein particularly during later stages
of development. By contrast, zebraﬁsh trpm7 mutant larvae undergo early morphogenesis normally and
thus do not have this limitation. The mutant larvae are characterized by multiple defects including
melanocyte cell death, transient paralysis, and an ion imbalance that leads to the development of kidney
stones. Here we report a requirement for Trpm7 in differentiation or function of dopaminergic neurons
in vivo. First, trpm7 mutant larvae are hypomotile and fail to make a dopamine-dependent develop-
mental transition in swim-bout length. Both of these deﬁcits are partially rescued by the application of
levodopa or dopamine. Second, histological analysis reveals that in trpm7 mutants a signiﬁcant fraction
of dopaminergic neurons lack expression of tyrosine hydroxylase, the rate-limiting enzyme in dopamine
synthesis. Third, trpm7 mutants are unusually sensitive to the neurotoxin 1-methyl-4-phenylpyridinium,
an oxidative stressor, and their motility is partially rescued by application of the iron chelator
deferoxamine, an anti-oxidant. Finally, in SH-SY5Y cells, which model aspects of human dopaminergic
neurons, forced expression of a channel-dead variant of TRPM7 causes cell death. In summary, a forward
genetic screen in zebraﬁsh has revealed that both melanocytes and dopaminergic neurons depend on the
ion channel Trpm7. The mechanistic underpinning of this dependence requires further investigation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Transient receptor potential melastatin-like 7 (TRPM7), a
widely-expressed divalent-cation channel with intrinsic kinase
activity, has cell-type- and context-dependent roles in cell survival
and physiology. Mouse and frog embryos depleted of the Trpm7
gene die during early morphogenesis (Jin et al., 2008; Liu et al.,
2011b; Ryazanova et al., 2010). Cell-lineage-speciﬁc deletion of
Trpm7 in mice indicates that Trpm7 is essential for the terminal
differentiation of thymocytes and of certain neural-crest deriva-
tives, including melanocytes and sensory neurons (Jin et al., 2008,
2012). Studies in cell lines or primary cells in vitro have suggested
roles for TRPM7 in Mg2þ homeostasis (Chubanov et al., 2004;
Nadler et al., 2001), cell proliferation (Hanano et al., 2004), cell
adhesion (Su et al., 2006), and cholinergic synaptic transmission
(Krapivinsky et al., 2006). The lack of TRPM7 causes cell-death due
to a disruption of magnesium homeostasis in some cell lines (Kim
et al., 2008; Nadler et al., 2001). Conversely, its presence appears
to sensitize at least one cell type to zinc-ion poisoning (Inoue et al.,
2010), and the reduction of TRPM7 expression in ﬁbroblasts
decreased markers of oxidative stress and increased cellular
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resistance to apoptotic stimuli (Chen et al., 2012). Moreover, when
extracellular levels of divalent cations drop below normal physio-
logical levels TRPM7 permits an inﬂux of Ca2þ which may
contribute to excitotoxicity (Aarts et al., 2003; Sun et al., 2009;
Wei et al., 2007). Supporting this model, reduction of Trpm7
expression in the rat hippocampus was found to lessen the
amount of neuronal cell death caused by ischemia (Sun et al.,
2009). In summary, studies in cell lines and limited tissue speciﬁc
knock-outs in rodents indicate that the physiological role for
TRPM7 is cell-type dependent.
Additional roles for Trpm7 in vertebrate development were
uncovered through forward genetics in zebraﬁsh. Independent
screens for mutations that disrupt melanophore development,
early motility, or adult growth each identiﬁed trpm7 mutants
(Arduini and Henion, 2004; Cornell et al., 2004; Elizondo et al.,
2005; Kelsh et al., 1996; Low et al., 2011). In trpm7 loss-of-function
mutants, embryonic melanophores (the melanin-producing cells
of ﬁsh) succumb to cell death (Arduini and Henion, 2004; Cornell
et al., 2004), and the melanosomes (the organelles that conﬁne
melanin) are structurally abnormal (McNeill et al., 2007). Because
Trpm7 is required within melanophores (Arduini and Henion,
2004; Cornell et al., 2004), the melanophore cell-death in trpm7
mutants may result from the release of toxic intermediates of
melanin synthesis into the cytoplasm (Hochstein and Cohen, 1963;
McNeill et al., 2007; Pawelek and Lerner, 1977). Additionally, trpm7
mutant larvae are unresponsive to touch for a period of about 12 h
during development (Arduini and Henion, 2004; Cornell et al.,
2004; Kelsh et al., 1996; Low et al., 2011). This phenotype can be
alleviated by forcing the expression of trpm7 in primary sensory
neurons, implying that Trpm7 is required transiently for function
or differentiation of embryonic primary sensory neurons (Low
et al., 2011). Finally, global homeostasis of divalent cations includ-
ing calcium and magnesium is abnormal in trpm7 mutant larvae
leading to aberrant calciﬁcation of developing bones. This suggests
a function for Trpm7 in the kidney-associated Corpuscle of
Stannius where it is highly expressed (Elizondo et al., 2005,
2010). Consistent with conservation of Trpm7 function at least in
some tissues, trpm7 mutant larvae exhibit bradycardia and mice
with depletion of Trpm7 in cardiac myocytes exhibit arrythmia
(Arduini and Henion, 2004; Sah et al., 2013). Analysis of zebraﬁsh
trpm7 mutant larvae has complemented mammalian studies.
Here we report additional analyses of a zebraﬁsh trpm7 mutant
and describe the consequences to a human dopaminergic cell-line
of reducing TRPM7 activity. We identify behavioral and develop-
mental defects in trpm7 mutants that can be partially reversed by
exogenous dopamine. Further we ﬁnd abnormal gene expression,
and increased sensitivity to a toxin, in dopaminergic neurons of
such mutants. Dominant negative interference with TRPM7 causes
death of the human dopaminergic cell line, suggesting a conserved
role for TRPM7 in dopaminergic neurons. In summary, the result of
a forward genetic screen in zebraﬁsh has identiﬁed a previously
unrecognized genetic requirement for Trpm7 in function and
possibly survival of dopaminergic neurons.
Methods
Fish and embryo rearing
All standard animal protocols were approved by the Institu-
tional Animal Care and Use Committee, and comply with USDA
laws as well as PHS Guidelines. Zebraﬁsh progeny and adults were
reared under supervision of the University of Iowa Animal Care
Unit, at 27.5 1C on a normal illumination cycle (i.e., 14 h light, 10 h
dark) unless otherwise noted. Embryos were generated and
handled following standard methods (Westerﬁeld, 1993), and
staged by hours post fertilization (hpf) at 28.5 1C (Kimmel et al.,
1995). The highly penetrant trpm7b508 (Elizondo et al., 2005), and
mitfaw2 (Lister et al., 1999) alleles were used for all experiments.
Until the beginning of each experiment, all ﬁsh were raised in ﬁsh
water (distilled water further puriﬁed by reverse osmosis and then
supplemented with 0.30 g Crystal Seas (Marinemix) (Marine
Enterprises International; Baltimore, MD) per liter).
Motility assay. Motility was monitored using ZebraBox and
Viewpoint software (version 3,10,0,42; Viewpoint Life Sciences,
Inc.; Montreal, Quebec, Canada) under infrared light. Larvae were
exposed to alternating cycles of light and dark, invisible to the
camera, every 30 min as described (Emran et al., 2008); each light
transition took approximately 1 ms. A 96-well plates (Costar) were
used for all experiments. At 4 days post fertilization (dpf), larvae
were singly placed in wells with 300 ml of ﬁsh water. Larvae were
placed into a 28.5 1C incubator on a normal light cycle overnight.
All experiments were completed in a quiet room at 5 dpf, between
10 AM and 2 PM. Larvae were allowed to acclimate in the Zebrabox
measurement apparatus for 2 h before recording began. Larval
locomotion was tracked with ViewPoint software. We deﬁned
motility as tracks moving less than 10 cm/s but more than 0.1 cm/
s. Location and distance traveled were recorded and binned every
5 min as presented in Fig. 2.
Cultured melanocytes
The 30 hpf control embryos, deﬁned as the wild-type and
heterozygous mutant siblings of trpm7 homozygous mutants,
and trpm7 homozygous mutant embryos (hereafter, trpm7
mutants), identiﬁed by the strong reduction of cutaneous mela-
nocytes, were transferred to calcium-free medium supplemented
with 0.05% trypsin and 5 mM EDTA, crushed with a plastic pestle,
incubated at 33 1C, and gently triturated every 10 min for 30 min.
Cultures were gently spun, the supernatant discarded, and the
tissue pellet resuspended in cell medium. Cells were cultured
overnight at 30 1C, and electrophysiology carried out at room
temperature (RT) the next morning. Cell medium, adapted from
(Badakov and Jazwinska, 2006), is DMEM (Gibco, Invitrogen,
Carlsbad, CA) supplemented with 15% (v/v) fetal bovine serum
(FBS; Atlanta Biologicals, Lawrenceville, GA), 100 units/ml penicil-
lin (Gibco), 100 mg/ml streptomycin (Gibco), 1% (v/v) trout serum
(Seagrow, product JJ80, East Coast Biologicals, North Berwick, ME),
20 ng/ml bovine insulin (Sigma, St. Louis, MO), 50 ng/ml basic
ﬁbroblast growth factor (Sigma), 62.5 mg/ml ampicillin, 25 ng/ml
epidermal growth factor (Sigma), 1% embryo extract. 100% embryo
extract consists of 200 embryos at 3 dpf rinsed in 0.5% bleach for
2 min then rinsed in calcium-free Ringer's solution (deﬁned in
(Westerﬁeld, 1993)) for 2 min; the embryos were homogenized
without liquid and suspended in 1 ml of cell mediumwithout fetal
bovine serum (FBS).
Cell culture and adenoviruses
The 293-TRPM7 cell line was employed to express hemagglu-
tinin (HA)-tagged murine TRPM7 and has been previously
described (Su et al., 2006). 293-TRPM7 cells were cultured in
Dulbecco's Modiﬁed Eagle Medium (D-MEM) with 10% FBS. The
overexpression of HA-tagged TRPM7 in 293-TRPM7 cells was
induced by the addition of tetracycline (1 mg/ml) to the growth
medium for 24 h. To assess the dominant-negative potential of the
TRPM7-E1047K pore mutant (TRPM7-DN), 293-TRPM7 cells were
treated with tetracycline and transiently transfected with pcDNA5/
FRT/TO-HA-TRPM7-E1047K, which has been previously described
(Li et al., 2007). SH-SY5Y cells were maintained in D-MEM/F-12
with 10% FBS and 5% horse serum, and were differentiated in
complete medium with 10 mM retinoic acid (RA), as previously
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described with the following modiﬁcations (Cheung et al., 2009).
SH-SY5Y cells were placed in differentiation medium for 3 days
prior to viral transduction. After the recombinant adenoviruses
were applied at a multiplicity of infection (M.O.I.) of 30, cells were
cultured in differentiation medium for another 3 days unless
otherwise speciﬁed. Cell viability was quantiﬁed by manual cell
counting and trypan blue exclusion. The recombinant adeno-
viruses expressing LacZ and GFP have been previously described
(Su et al., 2011). The recombinant adenovirus expressing TRPM7-
DN was engineered as follows. First, the AfeI/BglII fragment from
pcDNA5/FRT/TO-HA-TRPM7-E1047K was exchanged with the AfeI/
BgIII fragment from pENTR/D-TOPO-SR-TRPM7 to create pENTR/D-
TOPO-SR-TRPM7-E1047K. The SR-TRPM7-E1047K cassette was
then transferred to the destination vector pAd/CMV/V5-DEST
(Invitrogen) by recombination using the Gateways system (Invi-
trogen) following the manufacturer's instructions. The recombi-
nant adenoviruses expressing SR-TRPM7-DN was then made using
pAd/CMV/V5-SR-TRPM7-E1047K and the ViraPower Adenoviral
Expression System (Invitrogen) following the manufacturer's
instructions. The TRPM7-DN recombinant adenovirus was ampli-
ﬁed and concentrated from two 150 mm plates of HEK-293 A cells
(Invitrogen) using the Adenopack 100 kit (Sartorius Stedim Bio-
tech) following manufacturer's instructions.
Drug treatments
All drugs were purchased from Sigma-Aldrich (St. Louis, MO).
Levodopa (L-dopa; 20 mM) was applied with ascorbic acid
(100 mM) to delay oxidation of the former; ascorbic acid alone
was applied in control experiments. L-dopa was applied in the
morning at 5 dpf, and larvae were allowed to incubate for one
hour before behavior recordings began. Dopamine (DA; 20 mM)
was applied to both behavioral (free-swimming) and ﬁctive pre-
parations and had locomotor effects within 5 to 20 min, similar to
the time course reported in previous studies (Lambert et al., 2012;
Souza and Tropepe, 2011; Thirumalai and Cline, 2008). The effect
of DA on episode duration was quantiﬁed during 20–30 min into
the drug application. MPPþ was applied at 500 mM. It was
dissolved immediately prior to application at 50 hpf, and refreshed
daily. Larvae were ﬁxed for immunohistochemistry at 5 dpf. All
drugs were diluted in ﬁsh water except in the case of peripheral
nerve recordings (see below), in which drugs were diluted in
extracellular recording solution.
Whole-cell voltage clamp recordings
The cells were kept under continuous perfusion of standard
extracellular solution containing (in mM): 135 Na-methane-
sulfonate (Na-MeSO3), 5 CsCl, 1 CaCl2 and 10 HEPES, pH 7.4
(adjusted with NaOH). A volume of 1 μM tetrodotoxin (TTX) was
added to the extracellular buffer, in order to block voltage-gated
Naþ channel currents. Patch pipettes were pulled from borosili-
cate glass tubes (TW150F-4, World Precision Instruments, Sara-
sota, FL) and heat-polished at the tip to give a resistance of
3–5 mΩ when ﬁlled with the pipette solution containing (in
mM): 120 Cs-MeSO3, 5 CsCl, 2 CaCl2, 10 EGTA and 10 HEPES, pH
7.2 (adjusted with CsOH). The free Ca2þ concentration in the
pipette solution was calculated as 60 nM (MaxChelator, Stanford).
All currents were recorded at room temperature using an Axo-
patch 200B patch-clamp ampliﬁer (Molecular Devices, Sunnyvale,
CA), low-pass ﬁltered at 5 kHz and sampled at 10 kHz. All current
acquisitions were made with the pClamp10 software (Molecular
Devices, Sunnyvale, CA) and analyzed with Origin 7 software
(OriginLab Corporation, Northampton, MA). The holding potential
was 70 mV and the currents were recorded by applying a
voltage-ramp from 120 mV to þ100 mV for 500 ms. To
determine the Trpm7 current component, recordings were per-
formed from cells superfused with extracellular solution contain-
ing 10 mM NH4Cl or 10 mM MgCl2 for 2 min after the ﬁrst set of
recordings under standard extracellular conditions.
Whole-cell voltage clamp recordings of TRPM7 currents in 293-
TRPM7 cells were elicited by voltage stimuli lasting 250 ms
delivered every second using voltage ramps from 120 mV to
þ100 mV. Data were digitized at 2 kHz and digitally ﬁltered at
1 kHz. The internal pipette solution for macroscopic current
recordings contained (in mM) 145 Cs-methanesulfonate, 8 NaCl,
10 EGTA, and 10 4-(2-hydroxyethyl)-1-piperzineethanesulfonic
acid (HEPES), pH adjusted to 7.2 with CsOH. The extracellular
solution for whole-cell recordings contained (in mM) 140 NaCl,
5 KCl, 2 CaCl2, 20 HEPES, and 10 glucose, pH adjusted to
7.4 with NaOH.
Peripheral nerve recordings
Fictive swimming was assessed via peripheral nerve recordings
in vivo as described previously (Masino and Fetcho, 2005). Brieﬂy,
control and trpm7mutants were anesthetized with 0.02% Tricaine-
S (Western Chemical) in extracellular recording solution (Lambert
et al., 2012) and paralyzed with 0.1% (w/v) α-Bungarotoxin
(Sigma). Larvae were pinned in a lateral position to a Sylgard-
lined petri dish and the skin was removed. Subsequently, larvae
were transferred to the stage of an Olympus BX51 WI microscope
and extracellular recording solution was superfused continuously
at 1 ml/min at room temperature. Extracellular suction electrode
recording techniques (Masino and Fetcho, 2005) were used to
monitor the activity of peripheral nerves during ﬁctive behavior;
the tip of the extracellular suction electrode (6–15 mm tip dia-
meter) was positioned near the dorsoventral midline of an inter-
myotomal cleft where the skin had been removed. Spontaneous
activity was acquired for a minimum of 30 min for each prepara-
tion and, for experiments in which DA was applied, samples were
subsequently perfused with 20 mM DA in extracellular recording
solution. All recordings were between body segments 10 and 20. A
MultiClamp 700B (Molecular Devices, Sunnyvale, CA) ampliﬁer
was used to monitor extracellular voltage in current-clamp mode
at a gain of 2,000 (Rf¼50 MΩ), with the low- and high-frequency
cut-off at 300 and 1000 Hz, respectively. Recordings were sampled
at 10 kHz, digitized using a digitizing board (DigiData series
1440A, Molecular Devices, Sunnyvale, CA) and acquired using
pClamp 10 software. Analysis of peripheral nerve activity was
performed as described previously (Lambert et al., 2012; Wiggin
et al., 2012), using custom scripts written in MATLAB (Mathworks,
Natick MA). Brieﬂy, the occurrence times of rhythmic ﬁctive
locomotor bursts were determined from a rectiﬁed and smoothed
version of the voltage recording. These bursts were then grouped
into episodes and used to determine the episode durations for
each voltage trace. Values for ﬁctive episode durations are
expressed as mean7SEM (standard error of the mean).
Electroretinogram recordings
Electroretinograms (ERGs) were recorded as described pre-
viously (Lewis et al., 2011). Brieﬂy, 6 dpf larvae were anesthetized
in 0.02% Tricaine-S, and eyes were removed using a ﬁne tungsten
wire loop. Excised eyes were then placed in an oxygenated Ring-
er's solution (in mM; 130 NaCl, 2.5 KCl, 20 NaHCO3, 0.7 CaCl2,
1.0 MgCl2, and 20 glucose), and a glass electrode was positioned
directly onto the cornea. After 3 min of dark adaptation, eyes were
exposed to white light ﬂashes in the presence or absence of
background light, and their electrical responses were recorded.
Data were acquired and processed as described previously (Van
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Epps et al., 2001). Peak values are listed as the mean7SD
(standard deviation) from at least three animals.
Free-swimming assay
Video acquisition and analysis were performed as described
previously (Lambert et al., 2012). Brieﬂy, a group of 10 larvae in
embryo medium or embryo medium containing 20 mM DA was
placed in a 50 mm watch glass (Fisher Scientiﬁc) atop a trans-
mitted light stage (Schott TLS and MC-1500 LED Controller). The
larvae were allowed to acclimate to the recording arena for 5 min
prior to the start of video recording. Subsequently, spontaneous
free-swimming was recorded for 10 min at 60 frames per second,
using a digital CMOS camera (Point Grey, Fireﬂy M) with an
attached 50 mm macro lens (Sigma Corporation, Ronkonkoma,
NY). Videos were acquired with Fview (open-source software;
(Straw and Dickinson, 2009)), in uncompressed Fly Movie Format
(FMF). The FMF ﬁles generated by Fview were imported into the
California Institute of Technology Fly Tracker (Ctrax) (open-source
software; (Branson et al., 2009)) to obtain independent trajectories
of each target within the arena. We subsequently used the open-
source Fix Errors MATLAB Toolbox, provided by the creators of
Ctrax (Branson et al., 2009)), to identify and ﬁx tracking errors
(such as swapping of target identities). The total number of errors
per 10-min video was 4.4970.55 (n¼23 videos) and all errors
were corrected via the FEMT. Subsequently, scripts from the open-
source Behavioral Microarray MATLAB Toolbox, provided by the
creators of Ctrax (Branson et al., 2009), were implemented to
compute descriptive statistics of a suite of behavioral parameters
for each of the individual targets from the ﬁxed Ctrax trajectories.
The target speed function, velmag, was extracted for each target
and custom scripts were written to deﬁne and detect swimming
episodes using the same criteria as employed previously (Lambert
et al., 2012), namely: signal threshold of 1.5 mm/s, minimum
episode duration of 66.6 ms (4 frames), minimum average swim-
ming speed of 3 mm/s, and concatenation of signals within a
300 ms (18 frame) inter-signal interval. Identical ﬁlters were
applied for all videos across all ages and experimental groups.
Once all swimming episodes were identiﬁed, we quantiﬁed the
total distance traveled per individual in centimeters (sum of
instantaneous speeds during swimming episodes divided by the
frame rate) and mean swimming episode duration per individual
in milliseconds (mean duration from the onset to the offset of each
individual episode) over the 10-min recording period. Sample
sizes were ultimately smaller for quantifying episode duration
compared with total distance traveled because episode duration
could not be obtained from animals that did not move during the
recording session.
Histology
Larvae were ﬁxed in 4% paraformaldehyde overnight at 4 1C.
Whole-mount larvae were washed out of ﬁxative with double-
distilled water (ddH2O), permeabilized by either 5 h incubation at
room temperature in ddH2O or 30 min treatment with 40 mg/ml
ProtK, blocked in PBDT (Phosphate buffered solution, 2.5% Goat
serum, 1% bovine serum albumin, 1% DMSO, 0.5% Tritonx-100) for
1 h, and incubated in primary antibody [mouse anti-tyrosine
hydroxylase (1:500, Sigma-Aldrich) or rabbit anti-5HT] diluted in
PBDT overnight at 4 1C. In experiments where we used the
peroxidase anti-peroxidase system (Jackson Immunoresearch
Laboratories, West Grove, PA), we subsequently incubated
embryos in 21 goat anti-mouse antibodies and 31 mPAP antibody.
Samples were incubated in 1% hydrogen peroxide for 30 min in
between application of the 21 and 31 antibodies, and then developed
using 3-3′-diaminobenzidene (DAB, Sigma Aldrich). Whole-mount
larvae were alternatively prepared using Alexa 488 conjugated sec-
ondary antibodies and optically sectioned using a Zeiss 700 confocal
microscope and ZEN 2010 software (Carl Zeiss Inc., Germany). Optical
sections were compressed into single images by projecting the
maximum intensity signal of each pixel of each section using ImageJ
(National Institutes of Health) for approximately 500500150 mm
(width x heightdepth) at a resolution of 1.087 pixels per mm. In situ
hybridization for th2 and dat were carried out as described (Sallinen
et al., 2010).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Whole-animal mRNA was isolated at 5 dpf using Trizol (Invitro-
gen), from which cDNA was synthesized using oligo-dT(16) primers
and the cDNA SuperScript cDNA synthesis kit (Qiagen). MMLV enzyme
(Promega) was used for the reverse transcriptase reaction. Quantities
of mRNA were calculated relative to levels of beta-actin. Primers for
beta-actin forward 5′-gagatgatgcccctcgtg-3′ reverse 5′-gctcaatgggg-
tatttgagg-3′; th1 primers forward 5′-catatgtgacccgcatcaag-3′ reverse
5′-caacacattcagggcatctg-3′; th2 primers forward 5′-agcttcgtgtttgag-
gagga-3′ reverse 5′-ctctttctgctcgctcgact-3′; dat primers forward
5′-agacatctgggaaggtggtg-3′ reverse 5′-tgtagctggagaaggcgatt-3′; bdnf
primers forward 5′-tggcggcatccaggtagt-3′ reverse 5′-tcgaaggacgtt-
gacctgtatg-3′.
Statistics
Levene's test for equality of variances was used to test assump-
tions about error variances for Student's t-test. For experiments
that involved comparisons of two means, one-tailed Student's
t-tests were performed when error variances were equal. Signiﬁ-
cance was determined at the po0.05 level. A Welch t-test was
used instead when error variances were unequal. Multiple com-
parisons of means were made using two-way analysis of variance
and Bonferroni post-hoc tests. SPSS Statistics (IBM version 19 was
used for all above tests. A χ2 test was conducted assuming
Mendelian ratios of inheritance and 3 degrees of freedom, using
Microsoft Excel.
Calciﬁcation assays
Kidney stones were visualized as previously described
(Elizondo et al., 2005). Brieﬂy, live larvae were submerged in
0.004% alizarin red in Ringer's solution overnight. They were
washed 2 in Ringer's solution before visualizing live under
Texas Red ﬁlter.
Results
Sequence analysis of trpm7 cDNA generated from trpm7b508
mutants indicated that the encoded TRPM7 protein is truncated in
the cytoplasmic carboxy terminus upstream of the kinase domain;
however it did not clarify whether this variant retains channel
function (Elizondo et al., 2005). Application of a voltage ramp to
melanocytes isolated from wild-type embryos at 48 h post ferti-
lization (hpf) produced currents characteristic of those mediated
by TRPM7 (Fig. 1A). Subjecting rare surviving melanocytes isolated
from 48 hpf trpm7 mutants to the same procedure revealed that
these produce virtually no such current (Fig. 1B). These ﬁndings
suggest that, in vivo, trpm7b508 encodes a Trpm7 protein that
either lacks channel function or fails to reach the plasma mem-
brane. They are consistent with conclusions derived from forced
expression of trpm7b508 in Xenopus oocytes (Low et al., 2011).
Because an allele of TRPM7was reported to be associated with a
parkinsonian condition (Hermosura et al., 2005), we observed
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motility in zebraﬁsh trpm7 mutant larvae at 5 days post fertiliza-
tion (dpf). We monitored motility in larvae in alternating 30-min
periods of light and dark because the light-to-dark transition
strongly stimulates swimming (Burgess and Granato, 2007;
Emran et al., 2008). In dark periods and in light periods, trpm7
homozygous mutants traveled a shorter distance than their sib-
lings (wild-types and heterozygous mutants; hereafter, control
larvae) (Fig. 2, statistical analysis in the ﬁgure legend). In both
mutants and control larvae, motility was lower in light periods
than in dark periods; in light periods mutants were virtually still.
To test whether a deﬁcit in dopaminergic signaling causes hypo-
motility in trpm7 mutants, we treated trpm7 mutants and control
larvae with levodopa (L-dopa), a precursor of dopamine (DA), and
assayed their motility. In dark periods, L-dopa-treated mutants
moved signiﬁcantly more than vehicle-treated mutants, while L-
dopa treatment did not affect the motility of control larvae (Fig. 2).
The effectiveness of the light-to-dark stimulus depends on intact
visual processing and on non-visual light sensors (Emran et al.,
2008; Fernandes et al., 2012). To test whether vision is grossly
affected in trpm7 mutants we subjected larvae to micro-
electroretinography. We found that beta waves were indistin-
guishable between mutants and control larvae (Fig. S1). We
conclude that hypomotility of the mutants is unlikely to be caused
by abnormal vision or other gross defects. The simplest explana-
tion of these observations is that hypomotility in trpm7 larvae is at
least partly the result of sub-threshold dopaminergic signaling in
the central nervous system.
To test the possibility that dopaminergic signaling is lower than
normal in trpm7 mutants, we examined a developmental mile-
stone in zebraﬁsh that depends on intact dopaminergic signaling.
Between 3 and 4 dpf, wild-type zebraﬁsh larvae undergo a
developmental switch in their locomotor pattern, transitioning
from long to short swimming episodes (Buss and Drapeau, 2001;
Lambert et al., 2012). The latter pattern persists into adulthood
(Fuiman and Webb, 1988; Muller et al., 2000). This developmental
switch is mediated by central dopaminergic signaling, which
originates in the caudal diencephalon and acts in the spinal cord
via the diencephalospinal tract (Lambert et al., 2012). Using
videography, we measured swimming speed and episode duration
before (3 dpf) (Fig. S2) and after (5–6 dpf) (Fig. 3A, top) the
developmental switch. In addition to these behavioral parameters,
we measured the duration of ﬁctive swimming episodes by
carrying out extracellular recording of peripheral nerve activity
(Fig. 3A, bottom). At 3 dpf, there was no difference in episode
duration between trpm7 controls and mutants, regardless of
whether examined in the behavioral or ﬁctive swimming prepara-
tions (Fig. S2). However, at 5–6 dpf, the durations of behavioral
and ﬁctive episodes in trpm7 mutants were signiﬁcantly longer
than those of controls (Fig. 3A and B), indicating that the mutants
did not properly execute the stereotypic switch from long to short
episodes. By contrast, in 5–6 dpf trpm7 mutants treated with
20 mM exogenous DA, the episode duration during both the
behavioral and ﬁctive assays was signiﬁcantly shorter than in
untreated trpm7 mutants, but not different from that in controls
(Fig. 3A and B). Because the long-episode behavioral phenotype of
trpm7 mutants is recapitulated in the ﬁctive swimming prepara-
tion, and because the exogenous application of DA is sufﬁcient to
rescue the developmentally appropriate locomotor pattern, we
conclude that this phenotype is not caused by a deﬁcit in muscle
or body morphology but rather by to a lack of central dopaminer-
gic signaling (Lambert et al., 2012).
Fig. 2. The hypomotility of trpm7 mutants is levodopa responsive. Bar chart
showing results of automated analysis of motility was carried out during daytime,
over one cycle of 30 min exposure to light (white horizontal bar) followed by
30 min of darkness (black horizontal bar). Vertical bars indicate average distance
moved during 5 min intervals. The average movement of mutants over the hour
was signiﬁcantly lower than that of controls (Welch t-test, po0.001). For each
experiment, half of a single clutch of larvae from trpm7 heterozygous adults was
treated with 30 mM L-dopa for 3 h before recording. The motility of trpm7 mutants
was signiﬁcantly increased by L-dopa treatment during the ﬁrst 10 min after the
light-to-dark shift (Student's t-test, p¼0.004 and Welch t-test, p¼0.017 for the ﬁrst
and second 5 min intervals after the light-to-dark transition, respectively). By
contrast, control larvae were unaffected by L-dopa (Student's t-test, p¼0.097 and
p¼0.070 for the ﬁrst and second 5 min intervals after the light-to-dark transition,
respectively). Each group tested consisted of 22–24 animals. Error bars represent
SEM in one single hr. Asterisks, values signiﬁcantly different.
Fig. 1. The TRPM7-like current is dramatically reduced in trpm7b508 mutants.
Representative whole-cell current recordings of melanophores isolated at 32 hpf,
in (A) control or (B) trpm7 mutant embryos, in response to voltage ramps from
100 mV to þ100 mV for 500 ms. (A) Control melanocytes exhibited outwardly
rectifying currents that are potentiated by the extracellular application of 10 mM
NH4Cl, and inhibited by the application of 10 mM MgCl2, properties that are
characteristic of TRPM7-mediated currents. (B) The mutant melanophores did not
exhibit any TRPM7-like outwardly rectifying currents. The slight outward rectiﬁca-
tion of currents in mutant melanophores indicates that the cells were alive. Control,
n¼7 cells; mutant, n¼3 cells.
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We next used histology to determine if dopaminergic neurons
and other neuronal sub-types are present in trpm7 mutants.
Tyrosine hydroxylase is the rate-limiting enzyme in dopamine
synthesis. There are two orthologs of tyrosine hydroxylase in
zebraﬁsh, Th1 and Th2 (Chen et al., 2009; Filippi et al., 2009;
Holzschuh et al., 2001; Yamamoto et al., 2010). There is recent
evidence that Th2 contributes to serotonin synthesis in larvae (Ren
et al., 2013), although in some cells Th2 is detected together with
DA in the absence of Th1, implying it contributes to dopamine
synthesis (Yamamoto et al., 2011). Clusters of anti-Th1 immunor-
eactive (IR) cells (Th1 IR cells, hereafter) are present in several
discrete clusters within the brains of 5-dpf zebraﬁsh larvae
(Fig. 4M; the labeling scheme used here (Sallinen et al., 2009) is
compared to an alternative scheme (Rink and Wullimann, 2002) in
Table S1). The number of Th1 IR cells in all of these clusters
appeared grossly reduced in mutants in comparison to controls. To
quantify this effect, we focused on a cluster in the pretectum
(group 7), which is well-separated from the other clusters, and on
a cluster in the periventricular hypothalamus (group 13), because
neurons here exhibit a high level of immunoreactivity and are less
densely packed than elsewhere. We found that the number of Th1
IR cells in both clusters trended lower in trpm7 mutants than in
control larvae; this difference reached signiﬁcance in the pretec-
tum (Fig. 4A, B). The number of cells expressing th2, which are
found only in a preoptic cluster (group 3b), a diencephalic cluster
(group 8b), and a posterior paraventricular organ cluster (group
10b), was also clearly reduced in trpm7 mutants compared to
controls (Fig. 4K and L). The reduction in the number of th1- and
th2-expressing cells was mirrored by a reduction of the total
amount of th1 and th2 mRNA in mutants with respect to siblings,
as monitored by qRT-PCR (Fig. 5H). In contrast to expression of th
paralogs, expression of dopamine transporter (dat), a second
marker of dopaminergic neurons, appeared grossly equivalent in
trpm7 mutants and controls (Fig. 5E and F). Conﬁrming this
impression, we found the number of cells expressing GFP in the
Tg(dat:gfp) transgenic line (Xi et al., 2011) was not signiﬁcantly
different in trpm7 mutants relative to control larvae (Fig. 5C and
D). The number of sensory neurons in the dorsal root ganglia and
the number of serotoninergic neurons in the pretectum, recog-
nized by anti-Hu and anti-5-hydroxytryptophan (5HT) immunor-
eactivity, respectively, were equivalent in mutants and controls
(Fig. 5G and legend to Fig. 5). We also found no difference between
message levels of brain derived neurotrophic factor (bdnf), a gene
expressed in many regions of the brain (Fig. 5H). These ﬁndings
indicate that, in contrast to embryonic melanophores, which
undergo cell death, dopaminergic neurons and other categories
of neurons examined are present in normal numbers in trpm7
mutants. However, abnormally low expression of th paralogs in
such mutants indicates faulty differentiation or physiology of
dopaminergic neurons and possibly a subset of serotoninergic
neurons (i.e., those expressing Th2).
Embryonic melanophores in trpm7 mutants are poisoned by
the oxidative intermediates of melanin synthesis (McNeill et al.,
2007), and such intermediates are related to dopamine; therefore
we reasoned that dopaminergic neurons in trpm7 mutants may
similarly experience elevated levels of oxidative stress. In this case
they may be hypersensitive to oxidative stressors. The neurotoxin
1-methyl-4-phenylpyridinium ion (MPPþ) is transported by the
dopamine transporter into neurons, where it interferes with
complex I of the mitochondrial electron transport chain, depleting
the cell of ATP and elevating levels of reactive oxygen species
(ROS) (reviewed in Segura Aguilar and Kostrzewa, 2004). We
examined Th1 IR neurons in control and trpm7 mutant larvae
treated chronically with MPPþ . In control larvae, this treatment
caused a 15% reduction (relative to untreated larvae) in the
number of Th1 IR cells in the pretectal area, whereas in trpm7
mutants it caused a 50% reduction (relative to untreated trpm7
mutants) (Fig. 4A–D, I). The increased sensitivity of trpm7 mutants
to the effects of MPPþ was also apparent in the hypothalamus
(Fig. 4E–H, J). In principle, abnormally high levels of dat expression
might explain the elevated sensitivity to MPPþ , but we found that
the dat levels in mutants and siblings are comparable (as mea-
sured by qRT-PCR, Fig. 5H). Instead, the increased sensitivity of
trpm7 mutants versus control larvae to MPPþ implies that the
absence of Trpm7 elevates oxidative stress in DA neurons.
We next asked whether treatments that protect DA neurons from
MPPþ similarly protect them from the absence of Trpm7. Deferox-
amine (DFO) chelates iron and thereby inhibits the iron-catalyzed
conversion of hydrogen peroxide to the more highly reactive
hydroxyl ion (Menasche et al., 1987). DFO protects against degen-
eration of dopaminergic neurons induced by 6-hydroxydopamine
(6-OHDA) or MPTP (the MPPþ precursor) in animal models (Ben-
Shachar et al., 1992; Lan and Jiang, 1997). We treated trpm7
mutants and controls chronically with DFO and measured their
motility. Mutants treated with DFO moved signiﬁcantly more than
untreated mutants (Fig. 6), whereas control siblings were not
affected by DFO treatment. DFO treatment did not have a detect-
able effect on the number of Th1 IR cells or on the quality of
melanocytes in trpm7 mutants (data not shown). Of note, treat-
ment of trpm7 mutant larvae with DFO, similar to their treatment
with L-dopa, increased motility after the dark-to-light transition,
but not after the light-to-dark transition. This suggests that DFO
treatment partially rescues the function of dopaminergic neurons
in trpm7 mutants, and therefore that the defect in such neurons
Fig. 3. Dopamine rescues behavioral and ﬁctive locomotor patterns of the trpm7 mutant. (A) (Top row) Representative recordings of speed and (bottom row) extracellular
peripheral nerve recordings in ﬁctive swimming preparations for discrete swimming episodes of 5–6 dpf control siblings (left), trpm7 mutants (middle), and trpm7
mutantsþDA (20 mM; right). Grey bars below x-axes of speed plots represent episode durations whose beginnings and ends are deﬁned by the ﬁlter settings. (B) Summary
plot of the mean durations of behavioral and ﬁctive swimming episodes for each group. Asterisks indicate signiﬁcant difference; nnn po0.001. Numbers at the base of bars in
graph denote number of larvae observed for each experimental group. Error bars represent SEM.
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caused by the absence of Trpm7 is similar to that induced by 6-
OHDA or MPTP treatment.
Because parkinsonian features can result from the calciﬁcation of
basal ganglia (Koller et al., 1979), we considered the possibility that
the effects of Trpm7 on dopaminergic neurons may be indirect. As
previously reported (Elizondo et al., 2010), trpm7 mutant embryos
had signiﬁcantly more kidney stones than controls. However we did
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Fig. 5. Numbers of serotonergic neurons and neurons expressing dat are normal in trpm7mutants (A,B; A′,B′) Dorsal views of the (A and B) pre-tectum (Th1 group 7) and (A′
and B′) hypothalamus (Th1 group 13) in 5 dpf control and trpm7 mutant larvae, as indicated, processed to reveal anti-5HT (red) and anti-Th1 (green) immunoreactivity (IR).
Th1 IR cells were reduced in mutants (quantiﬁed in Fig. 4), 5HT IR cells were normal in number (below). Scale bar in A¼30 mm and applies to A–D; scale bar in A′¼50 mm and
applies to A′–B′ and E, F. (C and D) Dorsal views of 5 dpf Tg(dat:gfp) larvae focused on the pretectum (group 7). GFP-expressing neurons were equally abundant in trpm7
mutants and controls (control: 65 þ/- 7; mutant: 60 þ/- 10). (E and F) Ventral view of hypothalamus (group 13) in embryos of the indicated genotype processed to reveal dat
expression by in situ hybridization. (G) Bar chart indicating numbers of 5HT IR and GFP-expressing neurons within the pretectum (group 7) of trpm7 mutants (or trpm7
mutant; Tg(dat:gfp) transgenic) and controls. Number of neurons was not signiﬁcantly different between the genotypes. (Anti-Hu IR-positive cells in DRG caudal to hindyolk
at 5 dpf, control: 327 0, mutant: 3171). (H) qRT-PCR analysis of mRNA levels of th1, th2, dat, and bdnf. Asterisks indicate signiﬁcant difference; n po0.001. Error bars
represent SEM. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. trpm7 mutants are sensitized to MPPþ . (A–H) Dorsal views of 5-dpf larvae of the indicated genotype, treated with 500 mm MPPþ or vehicle control as indicated.
Individual panels show distinct groups of Th1 IR cells in the following brain regions: (A–D) pretectal diencephalon (group 7); (E–H) periventricular hypothalamus (group 13);
and I and J) bar chart showing average numbers of Th1 IR-positive cells in each group (n¼11 animals scored). In the untreated samples, the number of Th1 IR cells was
signiﬁcantly lower in mutants than controls in group 7 (control avg. þ/- SEM: 44 þ/- 2, mutant: 36 þ/- 2; Two way ANOVA with Bonferroni post-hoc test, po0.001).. In
group 13, (control: 56 þ/- 1, mutant: 51 þ/- 2) there was not a signiﬁcant difference in the number of Th1 IR cells between untreated controls and untreated mutants. In
both groups, MPPþ treatment effected a larger reduction in the number of Th1 IR cells in mutants than in controls (group 7, controlþMPPþ: 39 þ/- 2, mutantþMPPþ: 17
þ/- 2; group 13, controlþMPPþ: 53 þ/- 2, mutantþMPPþ: 37 þ/- 3). In group 7 the effect of MPPþ in mutants was almost three times larger than in controls, and in group
13 it was over four times larger; in both groups, mutants were signiﬁcantly more sensitive to MPPþ treatment than controls (po0.001). (K and L) Dorsal views of dissected
brains from (K) control or (L) trpm7 mutant larvae, processed to reveal th2 mRNA. The pre-optic area (group 3b) is outlined in white. (th2-positive cells: control: 14 þ/- 1,
n¼9; mutant: 7 þ/- 5, n¼12; po0.001). Scale bar in A¼50 mm, applies to A-H. Scale bar in K, ¼100 mm, applies to K,L. (M) Schematic illustrating the numbering scheme of
Th1 and th2 positive (outlined in black) neuron clusters where darkness indicates more ventral groups (1 olfactory bulb; 2 subpallium; 3–4 preoptic area; 5,6,11
diencephalon; 7 pretectum; 8 anterior paraventricular organ; 9 interior paraventricular organ; 10 posterior paraventricular organ; 12 posterior tuberal nucleus; 13
hypothalamus; 14 locus coeruleus; 15-16 medulla oblongata; 17 area postrema; see Table S1 for additional details) (modiﬁed from Sallinen et al., 2009).
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found no correlation between average distance moved in the light-
dark analysis and the presence of kidney stones (Pearson correlation
coefﬁcient of 0.015, n¼43, two-tailed p¼0.51). These ﬁndings
support the possibility that Trpm7 is required within dopaminergic
neurons in zebraﬁsh larvae, although this remains to be tested
experimentally.
Because of distinct phenotypes in zebraﬁsh and mouse Trpm7
loss-of-function mutants, it is unknown whether there is require-
ment for TRPM7 within mammalian dopaminergic neurons.
SH-SY5Y is a dopaminergic, neuroblastoma-derived cell line that
can be induced to differentiate in vitro (Encinas et al., 2000). We
infected SH-SY5Y cells with adenovirus encoding the TRPM7-
E1047K channel-pore mutant form of TRPM7 (TRPM7-DN), or
with a control adenovirus expressing LacZ. Electrophysiological
recordings in HEK-293 cells conﬁrmed our expectation that
TRPM7- E1047K acts in dominant-negative fashion, suppressing
wild-type TRPM7 currents (Fig. 7A and B). In comparison to non-
transduced and LacZ-expressing SH-SY5Y cells, TRPM7-DN-
expressing counterparts underwent cell death at an elevated
rate, whether or not they were induced to differentiate (Fig. 7C
and D). Treatment with DFO did not alleviate the toxicity of
TRPM7-DN (Fig. S3). These ﬁndings suggest that survival of a
human dopaminergic cell-line requires TRPM7 in a cell-
autonomous fashion.
Discussion
The zebraﬁsh trpm7 mutant provides an unusual opportunity
to explore the roles for Trpm7 in cell differentiation and physiol-
ogy at stages of development later than gastrulation, the stage
when mice and frogs depleted of Trpm7 die. Here we have
presented several pieces of evidence that in zebraﬁsh trpm7 loss-
of-function mutants there is defective function of dopaminergic
neurons leading to behavioral phenotypes. First, motility in trpm7
mutant larvae in the dark can be elevated by a concentration of
L-dopa that has no effect on sibling larvae. Tonic application of
L-dopa probably poorly mimics endogenous dopamine (DA) sig-
naling and may have indirect compensatory effects on Trpm
7-dependent neuronal populations controlling motility. Nonethe-
less, these ﬁndings suggest that within trpm7 mutants there is a
defect in the production or release of DA while other elements of
DA signaling relevant to motility remain intact. Second, the
observation that trpm7 mutants do not undergo the stereotypic,
DA-dependent developmental switch from long to short swim-
ming episodes but will do so if provided with exogenous DA also
suggests there lower-than-normal levels of dopaminergic signal-
ing in trpm7 mutants. It also implies that the signaling mechan-
isms and neural circuits that result in DA-mediated shortening of
swimming episodes, which were previously shown to be separable
from those that set motility levels (Lambert et al., 2012), function
properly. Third, the numbers of expressing th1-expressing and th2-
expressing neurons are modestly but signiﬁcantly reduced in
trpm7 mutant larvae in comparison to sibling larvae. A concomi-
tant reduction in DA production in the brain may account for
motility defects in mutants. We conducted an HPLC analysis of
biogenic amines in whole embryo lysates but, because of con-
founding effects of melanocytes, it was not sensitive enough to
detect changes in levels of biogenic amines of the magnitude as
changes in th expression (data not shown). A similar analysis of
isolated brains may sufﬁce to do so. Alternatively, the cause of
lower-than-normal dopaminergic signaling in Trpm7 mutants may
be other than reduced DA production; for instance there may be a
defect in evacuation of DA from synaptic vesicles, as has been
proposed in cholinergic vesicles (Brauchi et al., 2008; Krapivinsky
et al., 2006). Because motility of trpm7 mutants after a dark-to-
light transition is not measurably restored by L-dopa treatment,
there may be separate contributions of Trpm7 to motility other
than its role in development or function of DA neurons. There is a
recent report that Th2 has tryptophan hydroxylase activity (Ren
et al., 2013). While the number of neurons that are immunoreac-
tive for 5HT appears to be normal in Trpm7 mutant larvae,
we cannot rule out a role for Trpm7 in function of serotonergic
neurons. In summary, the physiological role of Trpm7 in motility
of 5 dpf zebraﬁsh larvae in dark periods is largely explained
by a direct or indirect requirement for Trpm7 in dopaminergic
neurons, while its role in motility in the light phase remains
unexplained.
The mechanistic underpinnings of the defect in the DA neurons
in trpm7 mutants remain unclear. However, two observations
suggest that in DA neurons, as in melanocytes but in contrast to
in other cell types (Chen et al., 2012), loss of Trpm7 elevates
oxidative stress. First, trpm7 mutants are unusually sensitive to
treatment with MPPþ , a toxin that raises levels of reactive oxygen
species and that prevents the differentiation of, and may kill,
dopaminergic neurons in zebraﬁsh (Burns et al., 1983; Heikkila
et al., 1985; Sallinen et al., 2010). Second, mutants treated with
DFO, an iron chelator and anti-oxidant that halts the Fenton
reaction, were more motile than untreated animals. How might
the loss of Trpm7 lead to increased oxidative stress in dopami-
nergic neurons in vivo? The primary defect may be a disruption of
cellular magnesium homeostasis, as organismal magnesium levels
are abnormal in zebraﬁsh trpm7 mutants (Elizondo et al., 2010),
and there is some evidence connecting abnormal cellular magne-
sium homeostasis and risk for Parkinson's disease (see references
in Kolisek et al., 2013). In zebraﬁsh trpm7 mutants, melanocytes
have abnormally shaped melanosomes and undergo cell death
that is rescued by inhibition of tyrosinase (McNeill et al., 2007).
Perhaps in the absence of Trpm7 the integrity of dopaminergic
vesicles is also compromised, and the toxic molecule dopamine
is released into the cytoplasm. How Trpm7 affects the integrity
of these vesicles is unknown, but it is noteworthy that calcium
channel blockers can cause a loss of the ATP-dependent proton
Fig. 6. DFO partially rescues hypomotility of trpm7 mutants. DFO treatment
increased spontaneous motility of 5-dpf, trpm7b508 mutant larvae. Automated
analysis of motility was carried out as in Fig. 2. For each experiment, half of a
single clutch of larvae from trpm7 heterozygous adults was treated with 50 mM DFO
from 2–5 dpf. Motility of control larvae was unaffected by DFO treatment (Student's
t-test, p40.4). Motility of the trpm7 mutant was signiﬁcantly increased by
treatment with DFO in darkness (Student's t-test, po0.05). Each group tested
consisted of 23–24 animals. Error bars represent SEM. Asterisks, signiﬁcantly
different values.
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gradient in catecholaminergic vesicles, reduce DA content, and can
promote cell death among dopaminergic neurons (Terland and
Flatmark, 1999). In summary, a plausible model that warrants
further testing is that in the absence of Trpm7, defective cation
homeostasis leads to elevated oxidative stress which disrupts
function, differentiation, and survival of dopaminergic neurons.
While there is no clear link between TRPM7 and any human
disorder, the mechanisms by which DA neurons are compromised
in the zebraﬁsh trpm7 mutants may be relevant to clinical
conditions. Amyotrophic lateral sclerosis/parkinsonian dementia
complex (ALS/PDC) is a disease to which epidemiologists have
long ascribed an environmental cause (Banack and Cox, 2003). A
variant of TRPM7 with increased sensitivity to inhibition by
magnesium was found to be over-represented in families with
ALS/PDC in Guam (Hermosura et al., 2005) but not in the Kii
peninsula of Japan (Hara et al., 2010). Evidence of a role for this ion
channel in function and maintenance of dopaminergic neurons
presented here supports further investigation into the possibility
that mutations in TRPM7 predispose individuals to ALS/PDC.
Indeed, zebraﬁsh trpm7 mutants may serve as a model for the
Fig. 7. Expression of TRPM7 dominant-negative (TRPM7-DN) suppresses differentiation by causing cell death. (A) Representative traces show the current-voltage
relationship in HEK-293 cells with expression of wild-type TRPM7 alone or with coexpression of wild-type TRPM7 and the TRPM7-E1047K pore mutant (TRPM7-DN). (B) Co-
expression of TRPM7-DN with wild-type TRPM7 in HEK-293 cells suppressed TRPM7 current densities at 120 mV and þ100 mV. (C) Representative phase-contrast images
of SH-SY5Y cells treated with retinoic acid (RA), at 4 and 6 days after plating. Shown are non-transduced (NT) cells, cells transduced with LacZ for 2 and 4 days, and cells
transduced with TRPM7-DN for 2 and 4 days. Scale bar¼200 mm. (D) Cell viability of non-transduced (NT), LacZ expressing, and TRPM7-DN expressing SH-SY5Y cells treated
with RA 6 days after plating and 3 days post-transduction. Viability of TRPM7-DN transduced and NT cells was signiﬁcantly different (Student's t-test, p¼0.006). Viability was
expressed as percent of non-transduced (% NT) cells.
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gene-environment interaction underlying ALS/PDC. Also, there is
an association between risks for Parkinson's disease and meta-
static melanoma (Liu et al., 2011a; Pan et al., 2011). This associa-
tion has been proposed to result from failure of a mechanism used
to contain quinone-related toxins in both dopaminergic neurons
and melanocytes (Hernandez, 2009); TRPM7 may contribute to
such a mechanism. Finally, stem cell-based therapies have the
potential to restore the damage caused by neurodegenerative
diseases. Such therapies require a clear understanding of the
mechanisms that govern the differentiation and survival of dopa-
minergic neurons, including the role of TRPM7 in these processes
(Hegarty et al., 2013).
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